Johnson & Johnson
- SEC CIK
- 0000200406
- Latest filing
- Aug 6, 2026
Holdings in Q2 2022
Holdings as of Jun 30, 2022, filed Aug 10, 2022. Long positions only; changes compare share counts with Q1 2022.
- Positions
- 22
- 0 vs. Q1 2022
- Portfolio value
- $391.5M
- −$137.5M (−26.0%) vs. Q1 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| LEGNLegend Biotech Corp | SPONSORED ADS | 1,629,173 | $89.6M | 22.9% | 00.0% | Unchanged | History |
| FATEFate Therapeutics Inc | COM | 3,379,064 | $83.7M | 21.4% | 00.0% | Unchanged | History |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 1,260,869 | $44.4M | 11.3% | 00.0% | Unchanged | History |
| PRCTPROCEPT BioRobotics Corp | COM | 1,018,478 | $33.3M | 8.5% | 00.0% | Unchanged | History |
| MGTXMeiraGTx Holdings plc | COM | 2,898,550 | $21.9M | 5.6% | 00.0% | Unchanged | History |
| CVRXCVRx, Inc. | COM | 3,495,575 | $21.0M | 5.4% | 00.0% | Unchanged | History |
| XNCRXencor Inc | COM | 748,062 | $20.5M | 5.2% | 00.0% | Unchanged | History |
| PTGXProtagonist Therapeutics, Inc | COM | 2,449,183 | $19.4M | 4.9% | 00.0% | Unchanged | History |
| HLTHCue Health Inc. | COM | 5,548,864 | $17.8M | 4.5% | 00.0% | Unchanged | History |
| ACETAdicet Bio, Inc. | COM | 728,944 | $10.6M | 2.7% | 00.0% | Unchanged | History |
| FUSNFusion Pharmaceuticals Inc. | COM | 3,670,516 | $9.14M | 2.3% | 00.0% | Unchanged | History |
| PNTPOINT Biopharma Global Inc. | COM | 1,000,000 | $6.81M | 1.7% | 00.0% | Unchanged | History |
| VORVor Biopharma Inc. | COM | 1,074,658 | $5.34M | 1.4% | 00.0% | Unchanged | History |
| NNOXNano-X Imaging Ltd. | ORD SHS | 192,429 | $2.17M | 0.6% | 00.0% | Unchanged | History |
| ALDXAldeyra Therapeutics, Inc. | COM | 394,834 | $1.57M | 0.4% | 00.0% | Unchanged | History |
| HLSQTessera Defense & Homeland Security Inc. | COM | 2,133,402 | $1.56M | 0.4% | 00.0% | Unchanged | History |
| SLGCSomaLogic, Inc. | CLASS A COM | 281,052 | $1.27M | 0.3% | 00.0% | Unchanged | History |
| PHASPhaseBio Pharmaceuticals Inc | COM | 1,607,044 | $964.0K | 0.2% | 00.0% | Unchanged | History |
| TCONTracon Pharmaceuticals, Inc. | COM NEW | 84,003 | $168.0K | <0.1% | 00.0% | Unchanged | History |
| GYREGyre Therapeutics, Inc. | COM NEW | 66,951 | $119.0K | <0.1% | 00.0% | Unchanged | History |
| SENSSenseonics Holdings, Inc. | COM | 54,621 | $56.0K | <0.1% | 00.0% | Unchanged | History |
| CALCCalciMedica, Inc. | COM SHS | 49,547 | $54.0K | <0.1% | 00.0% | Unchanged | History |